2-C-Methylerythritol 4-phosphate: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
CSV import
Line 28: Line 28:
{{Pharmacology-stub}}
{{Pharmacology-stub}}
{{No image}}
{{No image}}
== 2-C-Methylerythritol 4-phosphate gallery ==
<gallery>
File:MEP.png|MEP
</gallery>

Revision as of 05:41, 3 March 2025

2-C-Methylerythritol 4-phosphate (MEP) is a critical intermediate in the non-mevalonate pathway (also known as the MEP/DOXP pathway) of isoprenoid biosynthesis. This pathway is responsible for the production of essential isoprenoids in most bacteria, algae, and plants, but is absent in animals, making it an interesting target for the development of antibiotics, herbicides, and antimalarial drugs.

Biosynthesis

The MEP pathway begins with the condensation of pyruvate and glyceraldehyde 3-phosphate (G3P) to produce 1-deoxy-D-xylulose 5-phosphate (DXP). Through a series of enzymatic reactions, DXP is then converted to 2-C-methylerythritol 4-phosphate. The enzyme IspE catalyzes the conversion of MEP to 4-diphosphocytidyl-2-C-methyl-D-erythritol, a further step in the pathway leading to the production of isoprenoids.

Function

Isoprenoids, the products of the MEP pathway, are a large and diverse group of molecules that play crucial roles in various biological processes. They are involved in the synthesis of chlorophylls, carotenoids, plant hormones, and quinones. In bacteria, isoprenoids are essential for the synthesis of cell membrane constituents and electron transport chain components.

Clinical Significance

Due to its absence in humans, the MEP pathway is an attractive target for the development of new antimicrobial and antiparasitic agents. Inhibitors of the MEP pathway enzymes have shown potential as antibiotics against a range of bacteria and as antimalarial agents. For example, fosmidomycin, an inhibitor of the enzyme DOXP reductoisomerase (which acts early in the MEP pathway), has shown efficacy against Plasmodium falciparum, the parasite responsible for malaria.

Research

Research into the MEP pathway and its inhibitors is ongoing, with the aim of developing new therapeutic agents. Understanding the structure and function of the enzymes involved in the MEP pathway is crucial for the design of effective inhibitors.

See Also

External Links

Stub icon
   This article is a biochemistry stub. You can help WikiMD by expanding it!



This article is a stub related to pharmacology. You can help WikiMD by expanding it!

2-C-Methylerythritol 4-phosphate gallery